We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 17.75 | 17.50 | 18.00 | 17.75 | 17.75 | 17.75 | 58,159 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.25 | 16.19M |
Date | Subject | Author | Discuss |
---|---|---|---|
17/3/2019 11:31 | What's your source for this DIAMOND? | colinzeal | |
17/3/2019 11:28 | we should get an announcement about India soon, confidentiality clause signed on at least one big deal apparently. DIAMOND. | diamond fibre | |
17/3/2019 11:10 | Rayrac, this trashing of a company may well be diversion from your portfolio being down by 90%, eventually you need to address the horror. Go figure...if you can. :) | slartybartfaster | |
17/3/2019 10:40 | I’m afraid the tighter the stock spring gets wound the more we will see boiler room trolls and those with disruptive programs turning up. Take it as a sign of encouragement | belgrano2 | |
17/3/2019 09:07 | Morning John, :) :) | judijudi | |
17/3/2019 08:54 | Well, that was a bit of a weird intrusion from someone who's never had anything to do with this board before neftanikSTINKS. We do seem to attract all sorts. Oh, and I can vouch for Judijudi smells fine 🙂 John | 2350220 | |
17/3/2019 08:12 | New wrapping for an ineffective product...go figure? | rayrac | |
16/3/2019 21:21 | New packaging design is a huge improvement - imo | someuwin | |
16/3/2019 20:40 | Back on topic, been busy last week and missed the RNS. IMO this is very good news indeed and underpins the growth story and adds longevity to the sales pipeline. Not to be underestimated ARM Mk2...here we come | pol123 | |
16/3/2019 20:36 | neftanikSTINKS - what a load of tripe.....filtered | pol123 | |
16/3/2019 17:38 | Investors Chronicle-14/03/2019 I added a new holding to the portfolio: Scientific Digital Imaging (SDI). SDI designs and manufactures scientific and technology products | buywell3 | |
16/3/2019 16:53 | Nobbygnome, especially with go figure! ;) | rayrac | |
16/3/2019 08:23 | The biome industry and associated research is moving quickly. There.s some good research stuff coming into being around the bladder biome and associated conditions eg frequency, flows, C etc which is a massive area for development. The point I.m trying to make is that once the mechanisms and possible side effects are fully known (longer pharma studies reqd) our IP becomes way more valuable. Hoping the Bened (Pharma one?) work is progressing well. The idiots here in denial regarding growing revenues should be ignored. Our ip stuff reminds me of an early blinx - at the time, good tech, ringfenced - needed. I see a doubling in share price for starters, then take out. Biggest risk? Pharma research /approval failing. Gonna be big - hold on tight. | whitegold1 | |
15/3/2019 21:49 | FFS just filter him. You all know he has nothing meaningful to offer. Don't feed the troll!! | nobbygnome | |
15/3/2019 20:45 | I have a soft spot for obsessed pensioners...who have know idea what they are talking about Even funnier... I actually reckon Rayrac's got a holding and is trying reverse psychology...lol What a card | pol123 | |
15/3/2019 20:35 | I really cannot understand why the hell all of you have not filtered him | humphries1 | |
15/3/2019 19:58 | Empty vessels..........yaw | dire cons | |
15/3/2019 19:40 | Bahamas UKOG TRP And he’s advising serious investors on here rotflmfao | judijudi | |
15/3/2019 19:35 | And you! And make sure it’s not at other people’s expense? ! | rayrac |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions